Hereditary ATTR amyloidosis is a disease caused by the
deposition
of amyloid fibrils formed by mutated transthyretin (TTR), a protein
that binds to thyroid hormone in the serum, in the organs. The development
of a small molecule that binds to and stabilizes TTR is a promising
strategy for the treatment of ATTR amyloidosis. In the present study,
we demonstrated that the resveratrol derivatives including pterostilbene
available as a dietary supplement inhibit the fibrillization of V30M-TTR
to the same extent as the approved drug tafamidis. Furthermore, based
on a thermodynamic and X-ray crystallographic analysis, the binding
of the resveratrol derivative to TTR was shown to be enthalpy-driven,
with the binding enthalpy being acquired by hydrogen bonding to S117.
Moreover, direct observation of hydrogen atoms by neutron crystallography
provided details of the hydrogen bond network by S117 and emphasized
the importance of the CH···π interaction by L110
in the ligand binding.